Biotech Values

[DewDiligence]

ARWR…are they in the Hepatitis game with credible theory?

Just to be clear: ARWR has a phase-1 drug for hepatitis B (HBV), not hepatitis C (HCV). HBV is a much smaller treatment market than HCV in developed countries because there’s a vaccine that protects against HBV.